Using an Intrauterine Device in Immunocompromised Women
Authors:
- 1 September 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 112 (3) , 667-669
Abstract
Intrauterine devices (IUDs) are a viable treatment option for immunocompromised women who need contraception or menses suppression. They may also be an alternative treatment for women who have a contraindication to estrogen use. A review of the literature on IUD use in this population is sparse, but currently available data suggest that immunocompromised women are not at greater risk of developing pelvic infections.Keywords
This publication has 12 references indexed in Scilit:
- A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virusAmerican Journal of Obstetrics and Gynecology, 2007
- A Trial of Contraceptive Methods in Women with Systemic Lupus ErythematosusNew England Journal of Medicine, 2005
- Is the intrauterine device appropriate contraception for HIV-1-infected women?BJOG: An International Journal of Obstetrics & Gynaecology, 2001
- Intrauterine device and upper-genital-tract infectionThe Lancet, 2000
- Effect of intrauterine device use on cervical shedding of HIV-1 DNAAIDS, 1999
- Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patientContraception, 1999
- Complications of use of intrauterine devices among HIV-1-infected womenThe Lancet, 1998
- CONTRACEPTIVE PRACTICE IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUSRheumatology, 1993
- Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV.BMJ, 1992
- INTRAUTERINE CONTRACEPTIVE DEVICE FAILURES IN RENAL-TRANSPLANT PATIENTS1981